Open Access News

News from the open access movement

Friday, October 29, 2004

More on the Novartis funding for OA research

Jonathan Knight, Novartis goes public with DNA data in bid to tackle diabetes, Nature, October 28, 2004 (accessible only to subscribers). Excerpt: "It is rare for a private company to pay for a large public database. 'To make it public is a good move for science, but it is unusual,' says Sheldon Krimsky, a science-policy researcher at Tufts University in Medford,Massachusetts. Companies usually require a much more direct commercial benefit from such a partnership, he says. The project is likely to generate far more data than the company can use, says Tom Hughes, head of diabetes research at Novartis Institutes. Releasing it will help the field as a whole,which in turn could lead to other commercial opportunities, he suggests. 'We don't have to hold it all to ourselves to advance as a company.' "